Publications by authors named "Bruce Birmingham"

Claim this Profile
P
Population Pharmacokinetic Analysis of Zolmitriptan and Its Metabolite in Adults and Adolescents to Support Dose Selection in Children With Migraine.
Wangda Zhou, Jianguo Li, Bruce Birmingham, Hongmei Xu, Stefan Lillieborg

J Clin Pharmacol· October 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An Open-Label, Randomized Bioavailability Study of Alternative Methods of Oral Administration of Naloxegol in Healthy Subjects.
Khanh Bui, Bruce Birmingham, Ulysses Diva, Bruce Berger

Clin Pharmacol Drug Dev· July 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Fusidic Acid Inhibits Hepatic Transporters and Metabolic Enzymes: Potential Cause of Clinical Drug-Drug Interaction Observed with Statin Coadministration.
Anshul Gupta, Jennifer J Harris, Jianrong Lin, James P Bulgarelli, Bruce K Birmingham

Antimicrob Agents Chemother· October 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosuvastatin pharmacokinetics and pharmacogenetics in Caucasian and Asian subjects residing in the United States.
Bruce K Birmingham, Sarah R Bujac, Robert Elsby, Connie T Azumaya, Julie Zalikowski

Eur J Clin Pharmacol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of ABCG2 and SLCO1B1 polymorphisms on pharmacokinetics of rosuvastatin, atorvastatin and simvastatin acid in Caucasian and Asian subjects: a class effect?
Bruce K Birmingham, Sarah R Bujac, Robert Elsby, Connie T Azumaya, Cheryl Wei

Eur J Clin Pharmacol· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of CYP2C19 polymorphism on the pharmacokinetics of rosuvastatin in healthy Taiwanese subjects.
Richard D Finkelman, Tzung-Dau Wang, Yi Wang, Connie T Azumaya, Bruce K Birmingham

Clin Pharmacol Drug Dev· January 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetic and pharmacodynamic profile of rosuvastatin in patients with end-stage renal disease on chronic haemodialysis.
Bruce K Birmingham, Suzanne K Swan, Tom Puchalski, Pat Mitchell, Connie Azumaya

Clin Drug Investig· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of the effect of dapagliflozin on cardiac repolarization: a thorough QT/QTc study.
Glenn F Carlson, Conrad K P Tou, Shamik Parikh, Bruce K Birmingham, Kathleen Butler

Diabetes Ther· September 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Population pharmacokinetics of rosuvastatin: implications of renal impairment, race, and dyslipidaemia.
Tsang-Bin Tzeng, Dennis W Schneck, Bruce K Birmingham, Patrick D Mitchell, Harry Zhang

Curr Med Res Opin· September 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rosuvastatin pharmacokinetics and pharmacogenetics in white and Asian subjects residing in the same environment.
Edmund Lee, Stephen Ryan, Bruce Birmingham, Julie Zalikowski, Ruth March

Clin Pharmacol Ther· October 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of gemfibrozil on the pharmacokinetics of rosuvastatin.
Dennis W Schneck, Bruce K Birmingham, Julie A Zalikowski, Patrick D Mitchell, Yi Wang

Clin Pharmacol Ther· May 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis